PRTG Portage Biotech Corp Company Short-Term Debt

Portage Biotech Inc. (PRTG) is a biotech holding company recognized for its methods of accelerating the development of anti-tumor agents. The firm's investment strategy relies on managing biopharmaceutical assets to generate future royalties. This price chart on the GURU.Markets platform reflects a metric of 0.00. However, the company currently faces the threat of bankruptcy due to a shortage of funds to conduct medical trials.

To select high-quality assets, an investor must evaluate a business's ability to service its obligations over a short-term horizon. This metric aggregates all accounts payable with maturities of up to one year, which is critical for Portage Biotech Inc. (PRTG) amid frozen grants and capital shortages; therefore, the trend in total short-term debt serves as an indicator of the risk of an imminent cash crunch.